| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 476.70M | 388.30M | 295.30M | 265.70M | 212.00M |
| Gross Profit | 411.80M | 261.40M | 199.60M | 168.10M | 107.60M |
| EBITDA | 186.80M | 138.00M | 110.00M | 150.40M | 112.80M |
| Net Income | 41.50M | 64.80M | 70.70M | 120.60M | 57.80M |
Balance Sheet | |||||
| Total Assets | 5.22B | 4.09B | 2.38B | 1.79B | 1.28B |
| Cash, Cash Equivalents and Short-Term Investments | 3.24B | 2.07B | 1.60B | 1.04B | 609.90M |
| Total Debt | 547.80M | 2.32B | 1.28B | 711.40M | 355.80M |
| Total Liabilities | 4.03B | 2.90B | 1.66B | 1.02B | 563.80M |
| Stockholders Equity | 995.30M | 983.40M | 721.20M | 772.70M | 716.30M |
Cash Flow | |||||
| Free Cash Flow | 80.80M | 7.90M | 91.00M | 11.30M | 16.80M |
| Operating Cash Flow | 113.10M | 10.80M | 95.00M | 33.90M | 23.10M |
| Investing Cash Flow | -616.70M | -928.90M | -320.00M | -57.30M | -163.00M |
| Financing Cash Flow | 672.60M | 776.10M | 325.60M | -86.60M | 318.60M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £24.82B | 3.00 | 23.76% | 2.44% | 62.80% | 48.86% | |
76 Outperform | £1.66B | ― | 2.22% | 2.40% | 64.34% | 77.61% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | £4.35B | 5.37 | 23.35% | 4.13% | 28.34% | 44.04% | |
66 Neutral | £813.80M | -13.06 | 5.07% | 2.47% | 66.53% | 100.92% | |
54 Neutral | £2.02B | 110.86 | 4.25% | 2.85% | 62.91% | -15.13% | |
52 Neutral | £6.45B | 22.80 | 9.49% | 7.09% | 9.86% | -134.41% |